{
    "title": "Illumina defends $7.1 bln Grail buy to fend off antitrust regulators",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11535071/Illumina-defends-7-1-bln-Grail-buy-fend-antitrust-regulators.html",
    "date": "2022-12-13",
    "keywords": [
        "grail",
        "deal",
        "illumina",
        "acquisition",
        "detection",
        "test",
        "diane",
        "company",
        "inc",
        "dna",
        "vote",
        "law",
        "selling",
        "cancer",
        "approval",
        "europe",
        "ftcs",
        "judge",
        "marriott",
        "eu",
        "life",
        "tuesday",
        "biotech",
        "firm",
        "sequencing",
        "trade",
        "commission",
        "complaint",
        "march",
        "bid",
        "subsidiary",
        "agency",
        "provider",
        "multicancer",
        "refuse",
        "market",
        "blood",
        "takeover",
        "chief",
        "possibility",
        "court",
        "ftc",
        "hearing",
        "effort",
        "move",
        "illuminas",
        "advocate",
        "attorney",
        "david",
        "reason",
        "foot",
        "offer",
        "promise",
        "time",
        "matter",
        "regard",
        "supply",
        "support",
        "alternative",
        "punch",
        "december",
        "competition",
        "watchdog",
        "decision",
        "reporting",
        "bartz",
        "washington",
        "editing",
        "matthew",
        "lewis",
        "bradley",
        "perrett"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}